
Sign up to save your podcasts
Or
The FDA approval of TAVR for asymptomatic AS, digital health, subcutaneous vs transvenous ICD, and cryptogenic stroke in young adults are discussed by John Mandrola, MD.
This podcast is intended for healthcare professionals only.
To read a partial transcript or to comment, visit:
https://www.medscape.com/twic
I FDA announces approval for TAVR in pts with asymptomatic AS
II PPG that Can Distinguish source of Tachycardia
III PRAETORIAN -XL trial
IV Stroke in Young People
You may also like:
The Bob Harrington Show with the Stephen and Suzanne Weiss Dean of Weill Cornell Medicine, Robert A. Harrington, MD. https://www.medscape.com/author/bob-harrington
Questions or feedback, please contact [email protected]
4.9
824824 ratings
The FDA approval of TAVR for asymptomatic AS, digital health, subcutaneous vs transvenous ICD, and cryptogenic stroke in young adults are discussed by John Mandrola, MD.
This podcast is intended for healthcare professionals only.
To read a partial transcript or to comment, visit:
https://www.medscape.com/twic
I FDA announces approval for TAVR in pts with asymptomatic AS
II PPG that Can Distinguish source of Tachycardia
III PRAETORIAN -XL trial
IV Stroke in Young People
You may also like:
The Bob Harrington Show with the Stephen and Suzanne Weiss Dean of Weill Cornell Medicine, Robert A. Harrington, MD. https://www.medscape.com/author/bob-harrington
Questions or feedback, please contact [email protected]
129 Listeners
13 Listeners
316 Listeners
160 Listeners
483 Listeners
18 Listeners
280 Listeners
3,331 Listeners
87 Listeners
137 Listeners
1,095 Listeners
52 Listeners
179 Listeners
511 Listeners
322 Listeners
61 Listeners
25 Listeners
7 Listeners
407 Listeners
363 Listeners